Literature DB >> 21834767

Cytokine signaling modulates blood-brain barrier function.

Weihong Pan1, Kirsten P Stone, Hung Hsuchou, Vamshi K Manda, Yan Zhang, Abba J Kastin.   

Abstract

The blood-brain barrier (BBB) provides a vast interface for cytokines to affect CNS function. The BBB is a target for therapeutic intervention. It is essential, therefore, to understand how cytokines interact with each other at the level of the BBB and how secondary signals modulate CNS functions beyond the BBB. The interactions between cytokines and lipids, however, have not been fully addressed at the level of the BBB. Here, we summarize current understanding of the localization of cytokine receptors and transporters in specific membrane microdomains, particularly lipid rafts, on the luminal (apical) surface of the microvascular endothelial cells composing the BBB. We then illustrate the clinical context of cytokine effects on the BBB by neuroendocrine regulation and amplification of inflammatory signals. Two unusual aspects discussed are signaling crosstalk by different classes of cytokines and genetic regulation of drug efflux transporters. We also introduce a novel area of focus on how cytokines may act through nuclear hormone receptors to modulate efflux transporters and other targets. A specific example discussed is the ATP-binding cassette transporter-1 (ABCA-1) that regulates lipid metabolism. Overall, cytokine signaling at the level of the BBB is a crucial feature of the dynamic regulation that can rapidly change BBB function and affect brain health and disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21834767      PMCID: PMC3939622          DOI: 10.2174/138161211798220918

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  215 in total

Review 1.  Blood-brain barrier: structural components and function under physiologic and pathologic conditions.

Authors:  Yuri Persidsky; Servio H Ramirez; James Haorah; Georgette D Kanmogne
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-06       Impact factor: 4.147

2.  Developmental changes of leptin receptors in cerebral microvessels: unexpected relation to leptin transport.

Authors:  Weihong Pan; Hung Hsuchou; Hong Tu; Abba J Kastin
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

Review 3.  Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.

Authors:  Daniel S Straus; Christopher K Glass
Journal:  Trends Immunol       Date:  2007-11-05       Impact factor: 16.687

4.  Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes.

Authors:  Servio H Ramirez; David Heilman; Brenda Morsey; Raghava Potula; James Haorah; Yuri Persidsky
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

5.  ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier.

Authors:  Shin-ichi Akanuma; Sumio Ohtsuki; Youko Doi; Masanori Tachikawa; Shingo Ito; Satoko Hori; Tomoko Asashima; Tadafumi Hashimoto; Kaoru Yamada; Kazumitsu Ueda; Takeshi Iwatsubo; Tetsuya Terasaki
Journal:  Neurochem Int       Date:  2007-12-08       Impact factor: 3.921

Review 6.  A biophysical approach to IL-2 and IL-15 receptor function: localization, conformation and interactions.

Authors:  Andrea Bodnár; Eniko Nizsalóczki; Gábor Mocsár; Nikoletta Szalóki; Thomas A Waldmann; Sándor Damjanovich; György Vámosi
Journal:  Immunol Lett       Date:  2008-01-31       Impact factor: 3.685

7.  Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.

Authors:  Erin E McCandless; Laura Piccio; B Mark Woerner; Robert E Schmidt; Joshua B Rubin; Anne H Cross; Robyn S Klein
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

Review 8.  Urocortin and the brain.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-11-07       Impact factor: 11.685

9.  Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier.

Authors:  Shin-ichi Akanuma; Satoko Hori; Sumio Ohtsuki; Masachika Fujiyoshi; Tetsuya Terasaki
Journal:  Neurochem Int       Date:  2007-08-26       Impact factor: 3.921

10.  Soluble receptor inhibits leptin transport.

Authors:  Hong Tu; Abba J Kastin; Hung Hsuchou; Weihong Pan
Journal:  J Cell Physiol       Date:  2008-02       Impact factor: 6.384

View more
  77 in total

1.  Profiling of Cytokines Secreted by Conventional Aqueous Outflow Pathway Endothelial Cells Activated In Vitro and Ex Vivo With Laser Irradiation.

Authors:  Jorge A Alvarado; Phuonglan Chau; Jianfeng Wu; Richard Juster; Amde Selassie Shifera; Michael Geske
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

2.  Peripheral Immune System Adaptations and Motivation for Alcohol in Non-Dependent Problem Drinkers.

Authors:  Verica Milivojevic; Emily Ansell; Christine Simpson; Kristen M Siedlarz; Rajita Sinha; Helen C Fox
Journal:  Alcohol Clin Exp Res       Date:  2017-02-01       Impact factor: 3.455

Review 3.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

Review 4.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

5.  In vitro models of molecular and nano-particle transport across the blood-brain barrier.

Authors:  Cynthia Hajal; Marco Campisi; Clara Mattu; Valeria Chiono; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2018-05-31       Impact factor: 2.800

Review 6.  Sepsis-Associated Encephalopathy: The Blood-Brain Barrier and the Sphingolipid Rheostat.

Authors:  Stephen J Kuperberg; Raj Wadgaonkar
Journal:  Front Immunol       Date:  2017-06-16       Impact factor: 7.561

7.  Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.

Authors:  Juciano Gasparotto; Carolina S Girardi; Nauana Somensi; Camila T Ribeiro; José C F Moreira; Monique Michels; Beatriz Sonai; Mariane Rocha; Amanda V Steckert; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Daniel P Gelain
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

Review 8.  The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.

Authors:  Nicholas Dopkins; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Immunology       Date:  2018-02-27       Impact factor: 7.397

9.  Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor.

Authors:  Jacquelyn A Brown; Virginia Pensabene; Dmitry A Markov; Vanessa Allwardt; M Diana Neely; Mingjian Shi; Clayton M Britt; Orlando S Hoilett; Qing Yang; Bryson M Brewer; Philip C Samson; Lisa J McCawley; James M May; Donna J Webb; Deyu Li; Aaron B Bowman; Ronald S Reiserer; John P Wikswo
Journal:  Biomicrofluidics       Date:  2015-10-26       Impact factor: 2.800

10.  Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling.

Authors:  Suidong Ouyang; Hung Hsuchou; Abba J Kastin; Pramod K Mishra; Yuping Wang; Weihong Pan
Journal:  Brain Behav Immun       Date:  2014-02-24       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.